NASDAQ:STIM Neuronetics - STIM Short Interest Ratio & Short Volume Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Neuronetics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $2.92 -0.24 (-7.59%) (As of 03/22/2023 12:00 AM ET) Add Compare Share Share Today's Range$2.92▼$3.3250-Day Range$2.83▼$6.4352-Week Range$1.98▼$6.95Volume143,740 shsAverage Volume403,792 shsMarket Capitalization$79.48 millionP/E RatioN/ADividend YieldN/APrice Target$9.67 ProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsShort InterestSocial Media Neuronetics Short Interest DataCurrent Short Volume207,700 sharesPrevious Short Volume204,800 sharesChange Vs. Previous Month+1.42%Dollar Volume Sold Short$1.18 millionShort Interest Ratio / Days to Cover0.9Last Record DateFebruary 28, 2023Outstanding Shares27,220,000 sharesFloat Size25,560,000 sharesShort Percent of Float0.81%Today's Trading Volume143,740 sharesAverage Trading Volume403,792 sharesToday's Volume Vs. Average-64.40% Short Selling Neuronetics ? Sign up to receive the latest short interest report for Neuronetics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatSTIM Short Interest Over TimeSTIM Days to Cover Over TimeSTIM Percentage of Float Shorted Over Time Neuronetics (NASDAQ:STIM) Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/28/2023207,700 shares $1.18 million +1.4%0.8%0.9 $5.69 2/15/2023204,800 shares $1.21 million -8.6%0.8%0.9 $5.93 1/31/2023224,000 shares $1.32 million -17.1%0.9%1 $5.88 1/15/2023270,200 shares $1.69 million -13.6%1.1%1.2 $6.27 12/30/2022312,800 shares $2.15 million -28.4%1.3%1.5 $6.87 12/15/2022436,700 shares $2.90 million +120.3%1.8%2.2 $6.63 11/30/2022198,200 shares $1.24 million +18.8%0.8%1.1 $6.28 11/15/2022166,800 shares $817,320.00 -43.3%0.7%1.1 $4.90 10/31/2022294,200 shares $979,686.00 -11.8%1.2%2.5 $3.33 10/15/2022333,700 shares $917,675.00 -11.9%1.4%2.3 $2.75 9/30/2022378,900 shares $1.20 million -18.0%1.6%0.6 $3.18 9/15/2022461,900 shares $1.36 million +19.9%1.9%0.7 $2.94 8/31/2022385,200 shares $1.38 million -13.9%1.6%0.6 $3.57 8/15/2022447,400 shares $1.97 million -26.1%1.8%0.7 $4.40 7/31/2022605,400 shares $2.52 million +24.8%2.5%0.8 $4.17 7/15/2022485,300 shares $1.89 million -15.4%2.0%0.7 $3.90 6/30/2022573,700 shares $1.84 million -52.6%2.4%2.1 $3.21 6/15/20221,210,000 shares $4.30 million -2.4%5.0%4.1 $3.55 5/31/20221,240,000 shares $3.32 million -17.9%5.2%5 $2.68 5/15/20221,510,000 shares $3.88 million +43.8%6.2%5.7 $2.57 4/30/20221,050,000 shares $2.56 million +21.5%4.3%6.3 $2.44 4/15/2022864,300 shares $2.60 million +5.5%3.6%5 $3.01 3/31/2022818,900 shares $2.48 million -5.8%3.4%4.2 $3.03 3/15/2022869,500 shares $2.51 million -10.6%3.6%4.1 $2.89 2/28/2022972,400 shares $3.25 million +0.7%4.1%4.5 $3.34 2/15/2022965,900 shares $3.08 million +17.8%4.0%4.4 $3.19 1/31/2022820,200 shares $2.94 million +7.7%3.3%3.5 $3.58 1/15/2022761,600 shares $3.05 million -8.4%3.1%3.2 $4.01 12/31/2021831,400 shares $3.71 million -14.7%3.4%2.7 $4.46 12/15/2021975,000 shares $4.10 million +16.7%4.0%3.1 $4.21 11/30/2021835,500 shares $3.23 million +1.6%3.4%2.4 $3.87 11/15/2021822,400 shares $3.79 million -16.1%3.4%2 $4.61 10/29/2021979,800 shares $5.09 million -18.4%4.0%2.3 $5.20 10/15/20211,200,000 shares $5.83 million -45.2%4.9%2.3 $4.86 9/30/20212,190,000 shares $14.37 million +17.1%9.0%4.9 $6.56 9/15/20211,870,000 shares $12.25 million -11.8%7.6%3.7 $6.55 8/31/20212,120,000 shares $14.25 million +2.9%8.7%4.3 $6.72 8/13/20212,060,000 shares $17.43 million +29.6%8.4%4.5 $8.46 7/30/20211,590,000 shares $21.08 million -3.6%6.5%3.5 $13.26 7/15/20211,650,000 shares $22.31 million -14.1%7.1%3.4 $13.52 STIM Short Interest - Frequently Asked Questions What is Neuronetics' current short interest? Short interest is the volume of Neuronetics shares that have been sold short but have not yet been closed out or covered. As of February 28th, traders have sold 207,700 shares of STIM short. 0.81% of Neuronetics' shares are currently sold short. Learn More on Neuronetics' current short interest. What is a good short interest ratio for Neuronetics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. STIM shares currently have a short interest ratio of 1.0. Learn More on Neuronetics's short interest ratio. Which institutional investors are shorting Neuronetics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Neuronetics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Neuronetics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.81% of Neuronetics' floating shares are currently sold short. Is Neuronetics' short interest increasing or decreasing? Neuronetics saw a increase in short interest in February. As of February 28th, there was short interest totaling 207,700 shares, an increase of 1.4% from the previous total of 204,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Neuronetics' float size? Neuronetics currently has issued a total of 27,220,000 shares. Some of Neuronetics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Neuronetics currently has a public float of 25,560,000 shares. How does Neuronetics' short interest compare to its competitors? 0.81% of Neuronetics' shares are currently sold short. Here is how the short interest of companies in the industry of "surgical & medical instruments" compare to Neuronetics: NeuroPace, Inc. (7.87%), Neovasc Inc. (0.47%), Sensus Healthcare, Inc. (5.21%), Co-Diagnostics, Inc. (4.24%), Apyx Medical Co. (10.83%), Lucid Diagnostics Inc. (2.24%), Lyra Therapeutics, Inc. (0.05%), DarioHealth Corp. (5.72%), Pro-Dex, Inc. (0.49%), and Pulse Biosciences, Inc. (12.80%). Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Suncor Energy Inc. ($3.27 billion), Occidental Petroleum Co. ($2.77 billion), Coinbase Global, Inc. ($2.25 billion), T. Rowe Price Group, Inc. ($2.23 billion), Paramount Global ($1.92 billion), Etsy, Inc. ($1.75 billion), Voya Financial, Inc. ($1.74 billion), CarMax, Inc. ($1.62 billion), Old Dominion Freight Line, Inc. ($1.62 billion), and Royal Caribbean Cruises Ltd. ($1.39 billion). View all of the most shorted stocks. What does it mean to sell short Neuronetics stock? Short selling STIM is an investing strategy that aims to generate trading profit from Neuronetics as its price is falling. STIM shares are trading down $0.24 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Neuronetics? A short squeeze for Neuronetics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of STIM, which in turn drives the price of the stock up even further. How often is Neuronetics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including STIM, twice per month. The most recent reporting period available is February, 28 2023. More Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:STIM) was last updated on 3/23/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.